Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicOTC:RPBIF
Date12/2003
Raised
Post IPO Valuation

General Information

Websiteresponsebio.com
CategoryBioTech
Phone1-604-456-6010
Emailcustomersupport@r...
Employees
Founded1992

Offices

Vancouver, CAN
75th Avenue W
Vancouver, V6P 6P2, CAN

People

CEO
Chief Financial Officer

Funding

TOTAL $18.9M
FUNDING TOTAL $18.9M
Partial Close, 5/2009
$3.12M
Venture Round, 8/2010
$7.72M
Private Equity, 1/2012
$4.94M
Partial Close, 10/2013
$3.12M
DEBT TOTAL $2.77M
Debt, 12/2011
$265k
Debt, 2/2014
Silicon Valley Bank
$2.5M

Tags

Response Biomedical

Response Biomedical Corp. (“Response”) (TSX: RBM, OTCBB: RPBIF) develops, manufactures and markets rapid on-site diagnostic tests at its world class manufacturing facility in Vancouver, Canada, for use on the RAMP® Platform. The RAMP® Platform is sold worldwide and includes a variety of testing applications in the clinical, infectious disease, biodefense and environmental arenas. The RAMP® Platform provides laboratory quality results with the speed, precision and accuracy that many hospitals expect of their central lab systems. It is ideally suited for both point of care testing and laboratory use.

Recent Milestones

Videos

Screenshots

Response Biomedical screenshot
Above: Homepage
Uploaded: 9/6/13

Stock Price

Sources

  1. SEC (sec.gov) [edit]
  2. SEC (sec.gov) [edit]
  3. SEC (sec.gov) [edit]
  4. SEC (sec.gov) [edit]
  5. SEC (sec.gov) [edit]
  6. Response Biomedical Corp. Secures US$2.5 Million Term Loan (marketwired.com) [edit]
Edit This Page
Last Edited 2/18/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy